1. Home
  2. TNET vs PTGX Comparison

TNET vs PTGX Comparison

Compare TNET & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNET
  • PTGX
  • Stock Information
  • Founded
  • TNET 1988
  • PTGX 2006
  • Country
  • TNET United States
  • PTGX United States
  • Employees
  • TNET N/A
  • PTGX N/A
  • Industry
  • TNET Business Services
  • PTGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TNET Consumer Discretionary
  • PTGX Health Care
  • Exchange
  • TNET Nasdaq
  • PTGX Nasdaq
  • Market Cap
  • TNET 3.0B
  • PTGX 5.0B
  • IPO Year
  • TNET 2014
  • PTGX 2016
  • Fundamental
  • Price
  • TNET $55.78
  • PTGX $79.54
  • Analyst Decision
  • TNET Hold
  • PTGX Strong Buy
  • Analyst Count
  • TNET 4
  • PTGX 9
  • Target Price
  • TNET $77.33
  • PTGX $86.22
  • AVG Volume (30 Days)
  • TNET 500.5K
  • PTGX 1.3M
  • Earning Date
  • TNET 10-29-2025
  • PTGX 11-06-2025
  • Dividend Yield
  • TNET 1.97%
  • PTGX N/A
  • EPS Growth
  • TNET N/A
  • PTGX N/A
  • EPS
  • TNET 2.65
  • PTGX 0.72
  • Revenue
  • TNET $4,971,000,000.00
  • PTGX $209,217,000.00
  • Revenue This Year
  • TNET $2.49
  • PTGX N/A
  • Revenue Next Year
  • TNET $3.17
  • PTGX $140.23
  • P/E Ratio
  • TNET $21.06
  • PTGX $110.44
  • Revenue Growth
  • TNET N/A
  • PTGX N/A
  • 52 Week Low
  • TNET $54.61
  • PTGX $33.31
  • 52 Week High
  • TNET $98.51
  • PTGX $93.25
  • Technical
  • Relative Strength Index (RSI)
  • TNET 30.81
  • PTGX 62.21
  • Support Level
  • TNET $54.61
  • PTGX $75.44
  • Resistance Level
  • TNET $65.13
  • PTGX $80.43
  • Average True Range (ATR)
  • TNET 2.47
  • PTGX 2.61
  • MACD
  • TNET -0.46
  • PTGX -0.23
  • Stochastic Oscillator
  • TNET 6.32
  • PTGX 89.38

About TNET TriNet Group Inc.

Trinet Group Inc outsourced payroll and human capital management solutions for small and midsize businesses via a professional employer organization model. Under the PEO model, TriNet enters a co-employment arrangement and acts as the employer of record for administrative and regulatory purposes for clients' employees, known as worksite employees. Clients leverage the scale and expertise of TriNet to access competitive employee benefits, share employment risk liability, access compliance support, and outsource mission-critical day-to-day HR functions such as payroll and tax administration. Following the acquisition of Zenefits and Clarus R+D in 2022, TriNet derives the minority of its revenue from self-service HCM software and R&D tax credit services.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Share on Social Networks: